Can development alone save lives? trends and forecasts of congenital heart anomalies–attributable premature mortality in ASEAN
Open Access
- 21 April 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1698307
Abstract
Background: Congenital heart anomalies (CHAs) are a leading cause of premature childhood mortality and contribute substantially to years of life lost (YLL). Despite overall improvements in child survival in Southeast Asia, progress in reducing CHA-attributed mortality has been uneven. Examining how trends in CHA-related YLL align with socioeconomic development is critical for informing targeted health system investments. This study assesses trends and projections of CHA-attributed premature mortality in ASEAN countries from 2000 to 2030 in relation to development levels. Methods: Data from the Global Burden of Disease Study 2021 were used to extract CHA-attributed YLL rates, including all-age and age-stratified estimates ( 600 per 100,000). The estimated trends in Singapore and Brunei Darussalam exceeded those expected under the SDI-adjusted projections, with projected YLLs of 17.35 and 131.67 per 100,000 population, respectively. Conclusion: CHA-attributed premature mortality is largely preventable but not assured by development alone. Greater YLL reductions occur when investment in pediatric cardiac care keep pace with socioeconomic progress, highlighting the need for targeted interventions in countries with rising SDI but limited mortality reduction.Keywords
Funding Information
- Imperial College London
This publication has 37 references indexed in Scilit:
- Global, regional, and national burden of congenital heart disease, 1990–2021: a systematic analysis for the global burden of disease study 2021European Journal of Pediatrics, 2025
- The global, regional, and national patterns of change in the burden of congenital birth defects, 1990–2021: an analysis of the global burden of disease study 2021 and forecast to 2040eClinicalMedicine, 2024
- Addressing health inequities in Southeast Asia: challenges and opportunitiesThe Lancet Regional Health - Southeast Asia, 2024
- The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regionsThe Lancet Regional Health - Western Pacific, 2024
- Incorporating AI into cardiovascular diseases prevention–insights from SingaporeThe Lancet Regional Health - Western Pacific, 2024
- The 30 Years of Shifting in The Indonesian Cardiovascular Burden—Analysis of The Global Burden of Disease StudyJournal of Epidemiology and Global Health, 2024
- Failure to thrive in pediatric patients with congenital heart disease: a cross-sectional study of 13,256 patientsThe Lancet Regional Health - Western Pacific, 2024
- Healthier SG: Singapore’s multi-year strategy to transform primary healthcareThe Lancet Regional Health - Western Pacific, 2023
- Cardiac surgery in low-income settings: 10 years of experience from two countriesArchives of Cardiovascular Diseases, 2017
- Birth Prevalence of Congenital Heart Disease WorldwideJACC, 2011